Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v3.22.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net earnings (loss) $ 421 $ 1,262 $ (405)
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 537 562 606
Impairment of intangible assets and long lived assets 363   1,167
Stock-based compensation 72 64 71
Noncash interest expense 10 7 5
Share of (earnings) losses of affiliates, net 94 156 160
Realized and unrealized (gains) losses on financial instruments, net (99) 110 251
(Gains) losses on transactions, net (10) (224) 1
(Gains) losses on extinguishment of debt 1 40 (1)
Deferred income tax expense (benefit) (4) (356) (243)
Other noncash charges (credits), net 22 8 9
Insurance proceeds received for inventory loss 100    
Changes in operating assets and liabilities      
Decrease (increase) in accounts receivable 27 232 (18)
Decrease (increase) in inventory (440) 133 62
Decrease (increase) in prepaid expenses and other assets 76 39 15
(Decrease) increase in trade accounts payable 147 185 (122)
(Decrease) increase in accrued and other liabilities (92) 237 (274)
Net cash provided (used) by operating activities 1,225 2,455 1,284
Cash flows from investing activities:      
Cash proceeds from dispositions of investments 81 271  
Investments in and loans to cost and equity investees (202) (119) (141)
Capital expenditures (244) (257) (325)
Expenditures for television distribution rights (187) (56) (134)
Proceeds from sale of fixed assets 54    
Other investing activities, net (3)    
Net cash provided (used) by investing activities (501) (161) (600)
Cash flows from financing activities:      
Borrowings of debt 1,037 1,300 3,161
Repayments of debt (594) (2,079) (3,274)
Repurchases of Qurate Retail common stock (365) (70) (392)
Withholding taxes on net share settlements of stock-based compensation (29) (7) (7)
Payments for issuances of financial instruments (694) (69) (100)
Proceeds from settlements of financial instruments 311 79 16
Dividends paid to noncontrolling interest (60) (62) (40)
Dividends paid to common shareholders (503) (1,251)  
Other financing activities, net (17) (22) (25)
Net cash provided (used) by financing activities (914) (2,181) (661)
Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash (28) 20 (2)
Net increase (decrease) in cash, cash equivalents and restricted cash (218) 133 21
Cash, cash equivalents and restricted cash at beginning of period 814 681 660
Cash, cash equivalents and restricted cash at end of period $ 596 $ 814 $ 681